<div id="readability-page-1">Scott Braunstein, Chairman and CEO of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), recently executed several stock transactions, according to a filing with the Securities and Exchange Commission. The transactions come as the stock has experienced a significant 94.55% decline over the past year, according to InvestingPro data. Braunstein sold a total of 304,600 shares of Marinus common stock for approximately $167,530. The shares were sold at a...</div>

MRNS

<p>Scott Braunstein, CEO of Marinus Pharmaceuticals, sold 304,600 shares of the company's stock for about $167,530, as reported in a recent SEC filing. This sale occurs amid a significant decline in the stock's value, which has dropped 94.55% over the past year.</p>

Marinus Pharmaceuticals CEO Scott Braunstein sells $167,530 in stock